Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of these medicinal products is substantial. |
Clinical Added Value
| no clinical added value |
PECFENT does not provide any improvement in actual benefit (IAB V) compared to rapid-acting morphine drugs indicated in the management of break through pain in adult patients who take morphine drugs to treat chronic cancer pain. |
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
kk90gCb4mDzMKR5E
